UW Carbone Cancer Center

Madison, Wisconsin 53792

9 studies enrolling now · 18 studies all time

What they study most

Acute T Cell Leukemia Lymphoma, Advanced Breast Cancer, Advanced Cancer, Advanced Solid Tumors, Biliary Tract Cancer (BTC), Bladder Cancer, Bone Cancer, Bone Metastases, Bone Neoplasm, Breast Cancer, Breast Neoplasms, Burn Out

Studies at this site

• A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma — Recruiting now
• Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies — Recruiting now
• Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer — Recruiting now
• Study of 18F-FFNP Breast PET/MRI — Recruiting now
• Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer — Recruiting now
• Biomarkers to Detect Endocrine Therapy Resistance — Recruiting now
• Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors — Recruiting now
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — Recruiting now
• Outcomes and Cosmesis With Whole Breast Irradiation and Boost — Running, not enrolling
• Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC — Running, not enrolling
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) — Completed
• Tobacco Treatment Comparison for Cancer Care — Completed
• Interprofessional Mindfulness Practices Advancing Cancer Teamwork — Completed
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors — Available (expanded access)
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors — Completed